[1] |
Stöckler S,Holzbach U,Hanefeld F,et al.Creatine deficiency in the brain:a new,treatable inborn error of metabolism[J].Pediatr Res,1994,36(3):409-413.DOI:10.1203/00006450-199409000-00023.
|
[2] |
Mulik C,Mercimek-Andrews S.Creatine deficiency disorders:phenotypes,genotypes,diagnosis,and treatment outcomes[J].Turk Arch Pediatr,2023,58(2):129-135.DOI:10.5152/TurkArchPediatr.2023.23022.
|
[3] |
Lion-François L,Cheillan D,Pitelet G,et al.High frequency of creatine deficiency syndromes in patients with unexplained mental retardation[J].Neurology,2006,67(9):1713-1714.DOI:10.1212/01.wnl.0000239153.39710.81.
|
[4] |
Sun WH,Wang Y,Wu MY,et al.Fourteen cases of cerebral creatine deficiency syndrome in children:a cohort study in China[J].Transl Pediatr,2023,12(5):927-937.DOI:10.21037/tp-23-164.
|
[5] |
Wyss M,Kaddurah-Daouk R.Creatine and creatinine metabolism[J].Physiol Rev,2000,80(3):1107-1213.DOI:10.1152/physrev.2000.80.3.1107.
|
[6] |
Elbir Z,Oz F.Determination of creatine,creatinine,free amino acid and heterocyclic aromatic amine contents of plain beef and chicken juices[J].Food Sci Technol,2021,58(9):3293-3302.DOI:10.1007/s13197-020-04875-8.
|
[7] |
Joncquel-Chevalier Curt M,Voicu PM,Fontaine M,et al.Creatine biosynthesis and transport in health and disease[J].Biochimie,2015(119):146-165.DOI:10.1016/j.biochi.2015.10.022.
|
[8] |
Van de Kamp JM,Mancini GMS,Pouwels PJW,et al.Clinical features and X-inactivation in females heterozygous for creatine transporter defect[J].Clin Genet,2011,79(3):264-272.DOI:10.1111/j.1399-0004.2010.01460.x.
|
[9] |
Van de Kamp JM,Jakobs C,Gibson KM,et al.New insights into creatine transporter deficiency:the importance of recycling creatine in the brain[J].Inherit Metab Dis,2013,36(1):155-156.DOI:10.1007/s10545-012-9537-3.
|
[10] |
Goldstein J,Thomas-Wilson A,Groopman E,et al.ClinGen variant curation expert panel recommendations for classification of variants in GAMT,GATM and SLC6A8 for cerebral creatine deficiency syndromes[J].Mol Genet Metab,2024,142(1):108362.DOI:10.1016/j.ymgme.2024.108362.
|
[11] |
Salomons GS,van Dooren SJ,Verhoeven NM,et al.X-linked creatinetransporter gene (SLC6A8) defect: a new creatine-deficiency syndrome[J].Am J Hum Genet,2001,68(6):1497-1500.DOI:10.1086/320595.
|
[12] |
张赟健,丁一峰,李奕洁,等.SLC6A8 基因变异致脑肌酸缺乏综合征1 例患儿的临床与遗传学分析[J].中华医学遗传学杂志,2023,40(11):1397-1403.DOI:10:3760/cma.j.cn511374-20211025-00847.
|
[13] |
Passi GR,Pandey S,Devi ARR,et al.Cerebral creatine deficiency disorders - a clinical,genetic and follow up study from India[J].Brain Dev,2022,44(4):271-280.DOI:10.1016/j.braindev.2021.12.004.
|
[14] |
Bahl S,Cordeiro D,MacNeil L,et al.Urine creatine metabolite panel as a screening test in neurodevelopmental disorders[J].Orphanet J Rare Dis,2020,15(1):339.DOI:10.1186/s13023-020-01617-z.
|
[15] |
Van de Kamp JM,Betsalel OT,Mercimek-Mahmutoglu S,et al.Phenotype and genotype in 101 males with X-linked creatine transporter deficiency[J].Med Genet,2013,50(7):463-472.DOI:10.1136/jmedgenet-2013-101658.
|
[16] |
Rosenberg EH,Almeida LS,Kleefstra T,et al.High prevalence of SLC6A8 deficiency in X-linked mental retardation[J].Am.Hum Genet,2004,75(1):97-105.DOI:10.1086/422102.
|
[17] |
Li JQ,Xu SQ.Diagnosis and treatment of X-linked creatine transporter deficiency:case report and literature review[J].Brain Sci,2023,13(10):1382.DOI:10.3390/brainsci13101382.
|
[18] |
Miller JS,Thomas RP,Bennett A,et al.Early indicators of creatine transporter deficiency[J].J Pediatr,2019(206):283-285.DOI:10.1016/j.jpeds.2018.11.008.
|
[19] |
Curie A,Lion-François L,Valayannopoulos V,et al.Clinical characteristics,developmental trajectory,and caregiver burden of patients with creatine transporter deficiency (SLC6A8) [J].Neurology,2024,102 ( 8): e209243.DOI: 10.1212/WNL.0000000000209243.
|
[20] |
Yıldız Y,Göçmen R,Yaramış A,et al.Creatine transporter deficiency presenting as autism spectrum disorder[J].Pediatrics,2020,146(5):e20193460.DOI:10.1542/peds.2019-3460.
|
[21] |
Morey K,Hallinan B,Cecil KM.Case report:clinical and magnetic resonance spectroscopy presentation of a female severely affected with X-linked creatine transporter deficiency[J].Radiol Case Rep,2022,17(4):1115-1119.DOI:10.1016/j.radcr.2022.01.053.
|
[22] |
Abdennadher M,Inati SK,Rahhal S,et al.Characterization of seizures and EEG findings in creatine transporter deficiency due to SLC6A8 mutation[J].Am J Med Genet A,2024,194(2):337-345.DOI:10.1002/ajmg.a.63418.
|
[23] |
Desroches CL,Patel J,Wang P,et al.Carrier frequency of guanidinoacetate methyltransferase deficiency in the general population by functional characterization of missense variants in the GAMT gene[J].Mol Genet Genomics,2015,290(6):2163-2171.DOI:10.1007/s00438-015-1067-x.
|
[24] |
Hart K,Rohrwasser A,Wallis H,et al.Prospective identification by neonatal screening of patients with guanidinoacetate methyltransferase deficiency[J].Mol Genet Metab,2021,134(1-2):60-64.DOI:10.1016/j.ymgme.2021.07.012.
|
[25] |
Mercimek-Mahmutoglu S,Pop A,Kanhai W,et al.A pilot study to estimate incidence of guanidinoacetate methyltransferase deficiency in newborns by direct sequencing of the GAMT gene[J].Gene,2016,575(1):127-131.DOI:10.1016/j.gene.2015.08.045.
|
[26] |
Almaghrabi MA,Muthaffar OY,Alahmadi SA,et al.GAMT deficiency among pediatric population:clinical and molecular characteristics and management [ J ].Child Neurol Open,2023 ( 10 ):2329048X231215630.DOI:10.1177/2329048X231215630.
|
[27] |
Mercimek-Mahmutoglu S,Ndika J,Kanhai W,et al.Thirteen new patients with guanidinoacetate methyltransferase deficiency and functional characterization of nineteen novel missense variants in the GAMT gene[J].Hum Mutat,2014,35(4):462-469.DOI:10.1002/humu.22511.
|
[28] |
史晓依,孔九利,张玲玲,等.GAMT 基因变异所致脑肌酸缺乏综合征2 型1 例[J].中国临床案例成果数据库,2023,5(1):E01926.DOI:10.3760/cma.j.cmcr.2023.e01926.
|
[29] |
Schulze A,Tran C,Levandovskiy V,et al.Systemic availability of guanidinoacetate affects GABAA receptor function and seizure threshold in GAMT deficient mice[J].Amino Acids,2016,48(8):2041-2047.DOI:10.1007/s00726-016-2197-0.
|
[30] |
Poggio F,Brofiga M,Tedesco M,et al.Lack of epileptogenic effects of the creatine precursor guanidinoacetic acid on neuronal cultures in vitro[J].Biomolecules,2022,13(1):74.DOI:10.3390/biom13010074.
|
[31] |
Khaikin Y,Sidky S,Abdenur J,et al.Treatment outcome of twentytwo patients with guanidinoacetate methyltransferase deficiency:an international retrospective cohort study[J].Eur J Paediatr Neurol,2018,22(3):369-379.DOI:10.1016/j.ejpn.2018.02.007.
|
[32] |
Stockler-Ipsiroglu S,Van Karnebeek C,Longo N,et al.Guanidinoacetate methyltransferase (GAMT) deficiency: outcomes in 48 individuals and recommendations for diagnosis,treatment and monitoring[J].Mol Genet Metab,2014,111(1):16-25.DOI:10.1016/j.ymgme.2013.10.018.
|
[33] |
Libell JL,Lakhani DA,Balar AB,et al.Guanidinoacetate N-methyltransferase deficiency:case report and brief review of the literature[J].Radiol Case Rep,2023,18(12):4331-4337.DOI:10.1016/j.radcr.2023.09.026.
|
[34] |
Modi BP,Khan HN,Van der Lee R,et al.Adult GAMT deficiency:a literature review and report of two siblings[J].Mol Genet Metab Rep,2021(27):100761.DOI:10.1016/j.ymgmr.2021.100761.
|
[35] |
Item CB,Stöckler-Ipsiroglu S,Stromberger C,et al.Arginine:glycine amidinotransferase deficiency: the third inborn error of creatine metabolism in humans[J].Am J Hum Genet,2001,69(5):1127-1133.DOI:10.1086/323765.
|
[36] |
DesRoches CL,Bruun T,Wang P,et al.Arginine-Glycine amidinotransferase deficiency and functional characterization of missense variants in GATM[J].Hum Mutat,2016,37(9):926-932.DOI:10.1002/humu.23018.
|
[37] |
Stockler-Ipsiroglu S,Apatean D,Battini R,et al.Arginine:glycine amidinotransferase (AGAT) deficiency:clinical features and long term outcomes in 16 patients diagnosed worldwide[J].Mol Genet Metab,2015,116(4):252-259.DOI:10.1016/j.ymgme.2015.10.003.
|
[38] |
Battini R,Alessandrì MG,Casalini C,et al.Fifteen-year follow-up of Italian families affected by arginine glycine amidinotransferase deficiency[J].Orphanet J Rare Dis,2017,12(1):21.DOI:10.1186/s13023-017-0577-5.
|
[39] |
Finezilber Y,Massey C,Radley JA,et al.Arginine:glycine amidinotransferase (AGAT) deficiency:an easy-to-miss treatable adultonset myopathy[J].Pract Neurol,2024:pn-2023-003954.DOI:10.1136/pn-2023-003954.
|
[40] |
Mørkrid L,Rowe AD,Elgstoen KBP,et al.Continuous age- and sex-adjusted reference intervals of urinary markers for cerebral creatine deficiency syndromes:a novel approach to the definition of reference intervals[J].Clin Chem,2015,61(5):760-768.DOI:10.1373/clinchem.2014.235564.
|
[41] |
Sanders K,Peck D,Bentz Pino G,et al.SLC6A8 creatine transporter deficiency can be detected by plasma creatine and creatinine concentrations[J].Mol Genet Metab,2024,142(1):108455.DOI:10.1016/j.ymgme.2024.108455.
|
[42] |
van de Kamp JM,Mancini GM,Salomons GS.X-linked creatine transporter deficiency:clinical aspects and pathophysiology[J].J Inherit Metab Dis,2014,37(5):715-733.DOI:10.1007/s10545-014-9713-8.
|
[43] |
闫丽红,陆林,赵鑫,等.大脑肌酸缺乏综合征的临床表现及MRS 特征[J].医药论坛杂志,2021,42(23):52-56.DOI:1672-3422(2021)23-0052-05.
|
[44] |
Rostami P,Hosseinpour S,Ashrafi MR,et al.Primary creatinine deficiency syndrome as a potential missed diagnosis in children with psychomotor delay and seizure:case presentation with two novel variants and literature review[J].Acta Neurol Belg,2020,120(3):511-516.DOI:10.1007/S13760-019-01168-6.
|
[45] |
Abdennadher M,Inati SK,Rahhal S,et al.Characterization of seizures and EEG findings in creatine transporter deficiency due to SLC6A8 mutation[J].Am J Med Genet A,2024,194(2):337-345.DOI:10.1002/ajmg.a.63418.
|
[46] |
Riquin K,Isidor B,Mercier S,et al.Integrating RNA-Seq into genome sequencing workflow enhances the analysis of structural variants causing neurodevelopmental disorders[J].J Med Genet,2023,61(1):47-56.DOI:10.1136/jmg-2023-109263.
|
[47] |
Fernandes-Pires G,Braissant O.Current and potential new treatment strategies for creatine deficiency syndromes[J].Mol Genet Metab,2022,135(1):15-26.DOI:10.1016/j.ymgme.2021.12.005.
|
[48] |
Villar C,Campistol J,Fons C,et al.Glycine and L-arginine treatment causes hyperhomocysteinemia in cerebral creatine transporter deficiency patients[J].JIMD Rep,2012(4):13-16.DOI:10.1007/8904_2011_41.
|
[49] |
Mejdahl Nielsen M,Petersen ET,Fenger CD,et al.X-linked creatine transporter (SLC6A8) deficiency in females:difficult to recognize,but a potentially treatable disease[J].Mol Genet Metab,2023,140(3):107694.DOI:10.1016/j.ymgme.2023.107694.
|
[50] |
Schjelderup J,Hope S,Vatshelle C,et al.Treatment experience in two adults with creatinfe transporter deficiency[J].Mol Genet Metab Rep,2021(27):100731.DOI:10.1016/j.ymgmr.2021.100731.
|
[51] |
El-Gharbawy AH,Goldstein JL,Millington DS,et al.Elevation of guanidinoacetate in newborn dried blood spots and impact of early treatment in GAMT deficiency[J].Mol Genet Metab,2013,109(2):215-217.DOI:10.1016/j.ymgme.2013.03.003.
|
[52] |
Schulze A,Bachert P,Schlemmer H,et al.Lack of creatine in muscle and brain in an adult with GAMT deficiency[J].Ann Neurol,2003,53(2):248-251.DOI:10.1002/ana.10455.
|
[53] |
Ostojic SM.Benefits and drawbacks of guanidinoacetic acid as a possible treatment to replenish cerebral creatine in AGAT deficiency[J].Nutr Neurosci,2019,22(5):302-305.DOI:10.1080/1028415X.2017.1385176.
|